QA: Theseus Pharmaceuticals Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001745020_2023_Theseus_Pharmaceuticals_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001745020, Theseus Pharmaceuticals Inc.

  xvar xval
0 AssetsCurrent 0
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 416,000
3 remainder_Assets 222,031,000
4 LiabilitiesCurrent 11,130,000
5 LiabilitiesNoncurrent 3,236,000
6 remainder_Liabilities 466,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 18,388,000
9 ResearchAndDevelopmentExpense 35,698,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 3,478,000
13 remainder_ComprehensiveNetIncome -386,000
  yvar yval
0 Assets 222,447,000
1 Liabilities 14,832,000
2 Expenses 54,086,000
3 Revenues 0
4 StockholdersEquity 207,615,000
5 NetIncome -50,608,000
6 ComprehensiveNetIncome -50,801,000
7 BaseVar 147,614,500
8 EconomicCapitalRatio 2.58

Edgar->Model Mapping

Feature Distribution

Change over Time